Vanguard Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $5.68M | Buy |
|
|||||
|
2024
Q1 | $8.99M | Buy |
|
|||||
|
2023
Q4 | $6.04M | Buy |
|
|||||
|
2023
Q3 | $2.81M | Hold |
|
|||||
|
2023
Q2 | $4.86M | Sell |
|
|||||
|
2023
Q1 | $5.34M | Buy |
|
|||||
|
2022
Q4 | $10.5M | Buy |
|
|||||
|
2022
Q3 | $21.1M | Buy |
|
|||||
|
2022
Q2 | $8.01M | Sell |
|
|||||
|
2022
Q1 | $14.6M | Sell |
|
|||||
|
2021
Q4 | $26M | Buy |
|
|||||
|
2021
Q3 | $33.6M | Buy |
|
|||||
|
2021
Q2 | $54.9M | Buy |
|
|||||
|
2021
Q1 | $58.7M | Buy |
|
|||||
|
2020
Q4 | $37.7M | Buy |
|
|||||
|
2020
Q3 | $23.3M | Sell |
|
|||||
|
2020
Q2 | $49.9M | Buy |
|
|||||
|
2020
Q1 | $22.6M | Buy |
|
|||||
|
2019
Q4 | $53.2M | Buy |
|
|||||
|
2019
Q3 | $45.4M | Buy |
|
|||||
|
2019
Q2 | $60.6M | Buy |
|
|||||
|
2019
Q1 | $31.1M | Buy |
|
|||||
|
2018
Q4 | $32.5M | Sell |
|
|||||
|
2018
Q3 | $89.8M | Buy |
|
|||||
|
2018
Q2 | $42.3M | Sell |
|
|||||
|
2018
Q1 | $37.2M | Buy |
|
|||||
|
2017
Q4 | $15.2M | Buy |
|
|||||
|
2017
Q3 | $5.97M | Buy |
|
|||||
|
2017
Q2 | $1.29M | Buy |
|